Gubra company profile

GUBRA · Nasdaq Copenhagen · DKK

Compare Gubra
kr 265.00Change from previous close: −0.75%Absolute change: −kr 2.00

Close · November 20, 2026

Company profile

Gubra has 330 employees and is headquartered in Horsholm, Denmark.

Based in Horsholm, Denmark, and founded in 2008, Gubra works in peptide-based drug discovery and preclinical contract research. Its contract research and development services cover metabolic and fibrotic diseases and are offered to pharmaceutical and biotechnology companies in Europe, North America and other international markets. The services include in vivo pharmacology, biomarker assays, bioinformatics, next generation sequencing and histology with artificial intelligence pathology. Alongside these services, the company holds a portfolio of potential drug candidates that generates upfront, research and milestone payments and royalties, and it invests in assets promoting the green transition through its Gubra Green segment. Its collaborations include Boehringer Ingelheim on obesity, Camurus on hypoparathyroidism and Amylyx Pharmaceuticals on post-bariatric hypoglycemia.

In the fiscal year ended 31 December 2025, Gubra reported revenue of DKK 2.6 billion and net profit of DKK 1.7 billion. The company had 330 employees, and its headquarters are in Horsholm.

Company facts

Industry
Biotechnology
Country
Denmark
Headquarters
HOersholm Kongevej 11B, 2970, Horsholm
Employees
330
Chief executive
Markus Rohrwild
Founded
2008
Fiscal year
January - December
Listing
GUBRA · Nasdaq Copenhagen
Currency
DKK
ISIN
DK0062266474
Website
gubra.dk

Gubra and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
GubraGUBRADenmark$730.02M330-73.1%—
DBV TechnologiesDBVFrance$572.52M179-5,577.0%—
Pharming GroupPHARMNetherlands$841.25M40712.8%36.1
InventivaIVAFrance$890.8M87-5,980.9%—
PhilogenPHILItaly$905.96M23079.1%3.67
Basilea PharmaceuticaBSLNSwitzerland$1.07B20024.2%18.1

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Gubra with its competitors